SPPAM
COLL icon

Summit Partners Public Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Summit Partners Public Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-292,098
Closed -$6.97M – 88
2018
Q2 		$6.97M Sell
292,098
-151,528
-34% -$3.73M 0.77% 48
2018
Q1 		$11.3M Sell
443,626
-16,374
-4% -$390K 1.6% 21
2017
Q4 		$8.49M Buy
+460,000
New +$6.59M 1.11% 36

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Summit Partners Public Asset Management's COLL Position: Q3 2018 in Review

Summit Partners Public Asset Management sold out of Collegium Pharmaceutical (COLL) in Q3 2018, closing a stake of 292,098 shares — an estimated $6.97M sold.

Summit Partners Public Asset Management first reported a position in COLL in Q4 2017 and held it in 3 quarters. The position peaked at $11.3M in Q1 2018. 124 funds tracked by Wall St. Rank hold COLL as of Q3 2018.

  • Summit Partners Public Asset Management reported no remaining Collegium Pharmaceutical position as of Q3 2018 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 292,098 Collegium Pharmaceutical shares in Q3 2018, an estimated $6.97M.
  • Summit Partners Public Asset Management first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 3 quarters.
  • Summit Partners Public Asset Management's Collegium Pharmaceutical position peaked at $11.3M in Q1 2018.
  • 124 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2018.

Based on Summit Partners Public Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.